|
Market Closed -
Nasdaq Stockholm
09:30:00 14/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 3.330 SEK | -2.35% |
|
-4.86% | +126.53% |
| 23/07 | Sprint Bioscience AB and Eli Lilly and Company Enter Agreement to Accelerate Drug Development | CI |
| 26/06 | Four stocks have so far today posted new 52-week highs on the Stockholm Stock Exchange | FW |
| Market Cap | 35Cr 3.69Cr 3.19Cr 3Cr 2.73Cr 5.13Cr 353.31Cr 5.21Cr 14Cr 176.92Cr 14Cr 14Cr 587.95Cr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 35Cr 3.69Cr 3.19Cr 3Cr 2.73Cr 5.13Cr 353.31Cr 5.21Cr 14Cr 176.92Cr 14Cr 14Cr 587.95Cr | EV / Sales 2026 * |
4.14x | EV / Sales 2027 * | 2.27x |
| Free-Float |
64.78% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.35% | ||
| 1 week | -4.86% | ||
| Current month | -7.50% | ||
| 1 month | -9.02% | ||
| 3 months | -8.01% | ||
| 6 months | +53.46% | ||
| Current year | +126.53% |
| 1 week | 3.23 |  | 3.59 |
| 1 month | 3.21 | | 3.8 |
| Current year | 1.36 | | 4.59 |
| 1 year | 0.51 | | 4.59 |
| 3 years | 0.36 | | 4.59 |
| 5 years | 0.36 | | 5.55 |
| 10 years | 0.36 | | 41.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Johan Emilsson
CEO | Chief Executive Officer | 42 | 01/10/2023 |
Martin Andersson
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/01/2009 |
| Director of Finance/CFO | 55 | 04/05/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 01/01/2010 | |
Fredrik Lehmann
BRD | Director/Board Member | 50 | 01/01/2019 |
| Chairman | 58 | 01/01/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.35% | -4.86% | +456.86% | +568.67% | 3.69Cr | |
| -1.90% | +2.85% | +62.82% | +104.13% | 7.01TCr | |
| -3.21% | -4.32% | +31.85% | +57.27% | 5.29TCr | |
| -2.05% | -5.61% | -3.18% | +449.71% | 2.7TCr | |
| -1.27% | -1.57% | +45.90% | +8.25% | 2.36TCr | |
| +1.05% | -0.62% | -18.00% | -11.93% | 2.34TCr | |
| +3.81% | +20.97% | +266.37% | +531.28% | 1.94TCr | |
| +0.10% | +1.40% | +35.36% | -19.94% | 1.87TCr | |
| -0.95% | -3.52% | +19.93% | +594.00% | 1.59TCr | |
| +1.24% | -5.23% | +33.75% | +137.66% | 1.27TCr | |
| Average | -0.55% | +1.72% | +93.17% | +241.91% | 2.64TCr | |
| Weighted average by Cap. | -1.09% | +0.55% | +50.29% | +165.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.48Cr 89.17L 77.02L 72.37L 65.82L 1.24Cr 85Cr 1.26Cr 3.32Cr 43Cr 3.35Cr 3.28Cr 141.9Cr | 16Cr 1.63Cr 1.41Cr 1.32Cr 1.2Cr 2.26Cr 155.86Cr 2.3Cr 6.06Cr 78Cr 6.12Cr 5.99Cr 259.36Cr |
| Net income | - | - |
| Net Debt | - | - |
Employees
30
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | SEK 3.330 | -2.35% | 1,29,008 |
| 13/26/13 | SEK 3.410 | +5.57% | 2,94,484 |
| 12/26/12 | SEK 3.230 | -3.87% | 5,26,107 |
| 11/26/11 | SEK 3.360 | -2.33% | 1,49,248 |
| 10/26/10 | SEK 3.440 | -1.71% | 92,828 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- SPRINT Stock
Select your edition
All financial news and data tailored to specific country editions
